ORUM - Asset Resilience Ratio

Latest as of March 2025: 82.74%

ORUM (475830) has an Asset Resilience Ratio of 82.74% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩158.45 Billion

≈ $107.38 Million USD Cash + Short-term Investments

Total Assets

₩191.52 Billion

≈ $129.79 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how ORUM's Asset Resilience Ratio has changed over time. Check 475830 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down ORUM's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 475830 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩7.44 Billion	3.88%
Short-term Investments	₩151.02 Billion	78.85%
Total Liquid Assets	₩158.45 Billion	82.74%

Asset Resilience Insights

Very High Liquidity: ORUM maintains exceptional liquid asset reserves at 82.74% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

ORUM Industry Peers by Asset Resilience Ratio

Compare ORUM's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
ALTEOGEN Inc KQ:196170	Biotechnology	55.57%
Apogee Therapeutics, Inc. Common Stock NASDAQ:APGE	Biotechnology	47.01%
Definium Therapeutics, Inc. NASDAQ:DFTX	Biotechnology	34.94%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Inventiva S.A PA:IVA	Biotechnology	52.73%

Annual Asset Resilience Ratio for ORUM (2022–2024)

The table below shows the annual Asset Resilience Ratio data for ORUM.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	76.51%	₩117.70 Billion ≈ $79.76 Million	₩153.84 Billion ≈ $104.25 Million	-1.78pp
2023-12-31	78.29%	₩126.66 Billion ≈ $85.83 Million	₩161.78 Billion ≈ $109.64 Million	+21.51pp
2022-12-31	56.78%	₩12.09 Billion ≈ $8.19 Million	₩21.28 Billion ≈ $14.42 Million	--

pp = percentage points

About ORUM

KQ:475830 Korea Biotechnology

Market Cap

$293.91K

₩433.69 Million KRW

Market Cap Rank

#31083 Global

#2110 in Korea

Share Price

₩44600.00

Change (1 day)

+17.99%

52-Week Range

₩22000.00 - ₩143700.00

All Time High

₩143700.00